Back
Adverum Biotechnologies Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
32
ADVM
Adverum Biotechnologies
Last Price:
6.85
Seasonality Move:
-1.86%
Sell
40
EYPT
EyePoint Pharmaceuticals
Last Price:
8.22
Seasonality Move:
-9.25%
Sell
32
Adverum Biotechnologies (ADVM)
is a Sell
Is Adverum Biotechnologies a Buy, Sell or Hold?
- The current Adverum Biotechnologies [ADVM] share price is $6.59. The Score for ADVM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $8.01. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADVM Stock Price Chart
What is Adverum Biotechnologies's stock price today?
-
The Adverum Biotechnologies share price today is $6.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing selling pressure, which indicates risk of future bearish movement.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $8.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADVM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 42.65 | Sell |
Chaikin Money Flow: | -165680 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.74 - 7.22) | Sell |
Bollinger Bands (100): | (6.72 - 8.12) | Sell |
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 42.06 | Sell |
Chaikin Money Flow: | 232993 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.06 - 8.9) | Sell |
Bollinger Bands (100): | (8.03 - 10.53) | Sell |
ADVM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.88 | Sell |
20-day SMA: | 6.99 | Sell |
50-day SMA: | 7.07 | Sell |
200-day SMA: | 10.35 | Sell |
8-day EMA: | 6.86 | Sell |
20-day EMA: | 6.96 | Sell |
50-day EMA: | 7.19 | Sell |
200-day EMA: | 9.37 | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.22 | Sell |
20-day SMA: | 8.42 | Sell |
50-day SMA: | 8.66 | Sell |
200-day SMA: | 15.98 | Sell |
8-day EMA: | 8.2 | Sell |
20-day EMA: | 8.4 | Sell |
50-day EMA: | 8.83 | Sell |
200-day EMA: | 12.03 | Sell |
Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.62 per share, and an increase next year of $0.42 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Adverum Biotechnologies Technical Analysis
Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
EyePoint Pharmaceuticals Technical Analysis
Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |